Apuli Maricel
SEC CIK 2058197 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | CAO | 122.7K | — | $706.6K | 16 | 2025-03-19 | 2026-08-16 |
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 18:02 | 2026-08-16 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | F - Tax | $79.86 | -4,714 | 122.7K | -4% | -$376.5K | |
| T | 2026-08-03 16:20 | 2026-07-30 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | S - Sale | $80.06 | -2,000 | 127.4K | -2% | -$160.1K |
| 2026-05-19 16:26 | 2026-05-16 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | F - Tax | $66.13 | -4,714 | 129.4K | -4% | -$311.7K | |
| T | 2026-05-04 16:22 | 2026-04-30 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | S - Sale | $71.58 | -2,000 | 134.1K | -1% | -$143.2K |
| 2026-03-20 | 2026-03-18 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | A - Grant | $0.00 | +14.2K | 136.1K | +12% | $0 | |
| 2026-02-27 | 2026-02-26 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | S - Sale | $66.00 | -2,000 | 121.9K | -2% | -$132.0K | |
| 2026-02-18 | 2026-02-16 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | F - Tax | $75.25 | -4,349 | 124.5K | -3% | -$327.3K | |
| 2026-02-18 | 2026-02-17 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | S - Sale | $74.31 | -510 | 123.9K | -0.4% | -$37.9K | |
| 2025-12-16 | 2025-12-12 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | F - Tax | $75.15 | -2,003 | 128.3K | -2% | -$150.5K | |
| 2025-12-10 | 2025-12-08 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | S - Sale | $74.26 | -2,000 | 130.3K | -2% | -$148.5K | |
| 2025-11-18 | 2025-11-16 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | F - Tax | $66.39 | -4,781 | 132.3K | -3% | -$317.4K | |
| 2025-08-19 | 2025-08-16 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | F - Tax | $51.32 | -4,781 | 137.1K | -3% | -$245.4K | |
| 2025-08-11 | 2025-08-07 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | S - Sale | $45.44 | -1,000 | 141.9K | -0.7% | -$45.4K | |
| 2025-05-20 | 2025-05-16 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | F - Tax | $33.84 | -4,780 | 142.9K | -3% | -$161.8K | |
| 2025-05-06 | 2025-05-02 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | S - Sale | $38.51 | -1,026 | 147.6K | -0.7% | -$39.5K | |
| 2025-03-21 | 2025-03-19 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | CAO | A - Grant | $0.00 | +23.7K | 148.7K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations